Paxmedica, Common Stock Stock Price To Earning
PXMDDelisted Stock | USD 0.86 0.18 17.31% |
PaxMedica, Common Stock fundamentals help investors to digest information that contributes to PaxMedica, Common's financial success or failures. It also enables traders to predict the movement of PaxMedica, Pink Sheet. The fundamental analysis module provides a way to measure PaxMedica, Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PaxMedica, Common pink sheet.
PaxMedica, |
PaxMedica, Common Stock Company Price To Earning Analysis
PaxMedica, Common's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current PaxMedica, Common Price To Earning | 1.90 X |
Most of PaxMedica, Common's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PaxMedica, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, PaxMedica, Common Stock has a Price To Earning of 1.9 times. This is 92.65% lower than that of the Biotechnology sector and 61.46% lower than that of the Health Care industry. The price to earning for all United States stocks is 93.38% higher than that of the company.
PaxMedica, Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PaxMedica, Common's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PaxMedica, Common could also be used in its relative valuation, which is a method of valuing PaxMedica, Common by comparing valuation metrics of similar companies.PaxMedica, Common is currently under evaluation in price to earning category among its peers.
PaxMedica, Fundamentals
Return On Equity | -10.47 | ||||
Return On Asset | -2.56 | ||||
Current Valuation | 388.33 K | ||||
Shares Outstanding | 7.47 M | ||||
Shares Owned By Insiders | 8.14 % | ||||
Shares Owned By Institutions | 1.60 % | ||||
Number Of Shares Shorted | 637.72 K | ||||
Price To Earning | 1.90 X | ||||
Price To Book | 1.83 X | ||||
EBITDA | (16.15 M) | ||||
Net Income | (18.29 M) | ||||
Cash And Equivalents | 9.06 K | ||||
Total Debt | 173.54 K | ||||
Debt To Equity | 0.07 % | ||||
Book Value Per Share | 0.46 X | ||||
Cash Flow From Operations | (10.77 M) | ||||
Short Ratio | 0.10 X | ||||
Earnings Per Share | (11.00) X | ||||
Target Price | 3.0 | ||||
Market Capitalization | 5.14 M | ||||
Total Asset | 5.68 M | ||||
Retained Earnings | (52.03 M) | ||||
Working Capital | 3.89 M | ||||
Net Asset | 5.68 M |
About PaxMedica, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PaxMedica, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PaxMedica, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PaxMedica, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in PaxMedica, Pink Sheet
If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data |